Smart-glasses During the US-guided Radial Arterial Catheterization in Pediatric Patients: a RCT

February 17, 2021 updated by: Jin-Tae Kim, Seoul National University Hospital

The Usefulness of Smart-glasses During the Ultrasound-guided Radial Arterial Catheterization in Pediatric Patients: a Randomized Controlled Trial

The primary objective of the study is to evaluate the effect of smart glasses (Head-mounted display Moverio BT-300 (Epson Inc., USA)) on the first-attempt success rate of radial artery cannulation in pediatric patients. This study hypothesizes that the use of smart glasses improves the hand-eye coordination and the first-attempt success rate of radial artery cannulation. This is a single-center, randomized, placebo-controlled study comparing the real-time ultrasound image through smart glasses (intervention group) or the ultrasound machine's monitor (control group) during the radial arterial cannulation in pediatric patients undergoing general anesthesia.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

116

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 2 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • General anesthesia
  • Arterial cannulation for hemodynamic monitoring, multiple blood sample

Exclusion Criteria:

  • Unstable vital sign, significant arrhythmia or hypotension, Shock
  • High risk of peripheral ischemia
  • Skin disease, infection, hematoma, recent cannulation at radial artery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Smart Glasses
The real-time ultrasound image is displayed through head-mounted display Moverio BT-300 (Epson Inc., USA) during the radial arterial cannulation.
The real-time ultrasound image is displayed through head-mounted display Moverio BT-300 (Epson Inc., USA) during the radial arterial cannulation.
Placebo Comparator: Control
The real-time ultrasound image is displayed by the ultrasound machine's monitor during the radial arterial cannulation.
The real-time ultrasound image is displayed by the ultrasound machine's monitor during the radial arterial cannulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First attempt success rate
Time Frame: During radial artery cannulation (up to 1 hour)
Success at the first skin puncture
During radial artery cannulation (up to 1 hour)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Size of radial artery
Time Frame: Before and after subcutaneous injection of drugs (up to 1 hour)
Internal diameter of radial artery
Before and after subcutaneous injection of drugs (up to 1 hour)
depth of radial artery
Time Frame: During radial artery cannulation (up to 1 hour)
depth of radial artery from the skin
During radial artery cannulation (up to 1 hour)
Overall attempt
Time Frame: During radial artery cannulation (up to 1 hour)
Number of attempt of radial artery cannulation
During radial artery cannulation (up to 1 hour)
Overall Procedure time
Time Frame: During radial artery cannulation (up to 1 hour)
From needle puncture, to Arterial waveform
During radial artery cannulation (up to 1 hour)
Overall success rate
Time Frame: During radial artery cannulation (up to 1 hour)
Success within 2 skin puncture and within 10 minutes at the chosen radial artery
During radial artery cannulation (up to 1 hour)
Malfunction of radial artery catheter
Time Frame: After radial artery cannulation assessed during anesthesia (up to 24 hour)
Malfunction of Invasive blood pressure monitoring, Sampling
After radial artery cannulation assessed during anesthesia (up to 24 hour)
Complication rate
Time Frame: After radial artery cannulation assessed up to PACU, PICU stay (up to 24 hour)
Hematoma, Distal ischemia, Spasm accessed by ultrasound
After radial artery cannulation assessed up to PACU, PICU stay (up to 24 hour)
Operator's satisfaction
Time Frame: During radial artery cannulation (up to 1 hour)
Operator's satisfaction, 5 scale (Worst, Poor, Acceptable, Good, Best)
During radial artery cannulation (up to 1 hour)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2020

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

March 29, 2020

First Submitted That Met QC Criteria

March 30, 2020

First Posted (Actual)

April 1, 2020

Study Record Updates

Last Update Posted (Actual)

February 18, 2021

Last Update Submitted That Met QC Criteria

February 17, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Smart Glass A-line

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arterial Line

Clinical Trials on Smart glasses

Subscribe